Buy or Sell | Stay stock specific; buy Divis Labs, sell Aurobindo Pharma

Buy or Sell | Trade with positive bias; buy TCS, Tata Steel

Buy Or Sell | Trade with positive bias; buy Voltas, Maruti

Buy or Sell | Trade with positive bias; buy TCS, Tech Mahindra

Buy Or Sell | Trade with a positive bias till support of 11600 holds

Buy or Sell | Maintain positive bias on markets

Buy or Sell | Trade with positive bias, Nifty has support at 11,450

Buy Or Sell | Trade with positive bias, Nifty has support at 11,450

Buy or Sell | Trade with positive bias, Nifty may test 11300-11350

Buy Or Sell | Nifty likely to test 10650; Buy HDFC Bank, sell Apollo Tyres

Buy Or Sell | Valuations of HDFC AMC will not sustain: Time to sell?

Buy or Sell | Upside likely to remain capped; buy NMDC, Jubilant Food, HDFC Bank

Technical view | Buy Divis Labs with stop loss at Rs 1,590

Market Headstart: Nifty seen opening higher; Kansai Nerolac Paints, Jyothy Labs top buys

Buy or Sell | Positive on market in long term, buy Kajaria Ceramics

Buy or Sell | Buy on dips, broader market to show positive momentum

Buy or Sell | Outlook remains positive with some volatility; buy M&M

Buy or Sell | Positive on market, banks likely to outperform

Buy Or Sell | Remain positive on markets; resistance near 11,200

Buy or Sell | Stay positive till 10,800 is not breached

Q1 Review: Dr Reddy's MV Ramana On Earnings & FY23 Targets

Davos 2022 | Dr Reddy's GV Prasad On Post-Pandemic Health & Pharma Industry Opportunities

Q4 Results: Dr Reddy's MV Ramana On Earnings & FY23 Growth Projections

Dr Reddy Laboratories Plant Gets EIR From U.S. FDA For Its Visakhapatnam Facility

Earnings Previews: SBI, Dr. Reddy's, Cipla, HPCL & IOC

Sensex Rejig: Dr. Reddy’s Loss Is Vedanta’s Gain

Trade Setup for Thursday: Top 15 things to know before Opening Bell

Karvy delays broking payouts: Investors send SOS to Centre, FinMin & SEBI

Technical Views by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

Market Headstart: Nifty likely to open lower; Rallis India, Granules top picks

3 Point Analysis | Sequent Scientific Q2 Review

Karvy delays broking payouts- Investors send SOS to Centre, FinMin & SEBI